Rex Medical Receives 510(k) Clearance for Revolution Peripheral Atherectomy System
Technology | Atherectomy Devices | September 13, 2019

September 13, 2019 — Rex Medical L.P. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA...

CorWave Presents First Successful In Vivo 60-day Study of Neptune LVAD
News | Ventricular Assist Devices (VAD) | September 12, 2019

September 12, 2019 — CorWave announced successful completion of its first 60-day preclinical study to evaluate its...

Corvia Medical and physIQ Partner in Global Phase 3 Heart Failure Device Clinical Trial

The REDUCE LAP HF-II study will combine Corvia Medical's InterAtrial Shunt Device (IASD), pictured here, with physIQ's continuous monitoring platform to evaluate the device's efficacy in patients with heart failure. Image courtesy of Corvia Medical.

News | Heart Failure | September 12, 2019

September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a...

HeartFlow Announces FDA Clearance for HeartFlow Planner
Technology | CT Angiography (CTA) | September 12, 2019

September 12, 2019 — HeartFlow Inc. has obtained clearance from the U.S. Food and Drug Administration (FDA) for the...

Reducing Secondary Mitral Regurgitation in Heart Failure Does Not Improve Two-year Outcomes
News | Heart Valve Technology | September 11, 2019

September 11, 2019 — Percutaneous reduction of...

 Tiny Wearable Cameras May Improve Quality of Life in Heart Failure Patients

Image courtesy of Amazon.com

News | Heart Failure | September 11, 2019

September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse,...

PARAGON-HF Misses Endpoint in Preserved Heart Failure
News | Heart Failure | September 11, 2019

September 11, 2019 — The angiotensin...

Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019

September 10, 2019 — An international randomized trial has shown that complete revascularization reduces major...

Prasugrel Cuts Ischemic Events in Acute Coronary Syndrome Patients
News | Antiplatelet and Anticoagulation Therapies | September 09, 2019

September 9, 2019 — Prasugrel is superior to ticagrelor for reducing ischemic events in patients with acute coronary...

Farxiga Significantly Reduces Cardiovascular Death and Worsening of Heart Failure
News | Heart Failure | September 09, 2019

September 9, 2019 — AstraZeneca announced detailed results from the landmark Phase III DAPA-HF...

The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI

Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...

ESC President Barbara Casadei, M.D., DPhil, FRCP, FESC, a British Heart Foundation Professor and an honorary consultant cardiologist at the John Radcliffe Hospital in Oxford, speaks at a press conference at the 2019 ESC Congress. #ESC19 #ESC2019

ESC President Barbara Casadei, M.D., DPhil, FRCP, FESC, a British Heart Foundation Professor and an honorary consultant cardiologist at the John Radcliffe Hospital in Oxford, speaks at a press conference at the 2019 ESC Congress.

 

Feature | ESC | September 09, 2019

September 9, 2019 — More than 33,000 health professionals gathered over five days to attend the 2019...

Overlay Init